MannKind Corp
MNKD
#6215
Rank
HK$7.17 B
Marketcap
HK$23.22
Share price
-0.84%
Change (1 day)
-33.57%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): HK$11 Million

According to MannKind Corp's latest financial reports the company's current earnings are HK$0.34 Billion. a decrease over its 2024 earnings that were of HK$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 HK$11.02 M-95.39%
2024 HK$0.23 B-394.09%
2023 -HK$81.28 Million-88.13%
2022 -HK$0.69 Billion8%
2021 -HK$0.64 Billion40.84%
2020 -HK$0.46 Billion10.7%
2019 -HK$0.41 Billion-40.16%
2018 -HK$0.68 Billion-26.04%
2017 -HK$0.92 Billion-193.33%
2016 HK$0.98 B-134.11%
2015 -HK$2.89 Billion85.72%
2014 -HK$1.56 Billion3.6%
2013 -HK$1.5 Billion12.79%
2012 -HK$1.33 Billion5.58%
2011 -HK$1.26 Billion-5.72%
2010 -HK$1.34 Billion-22.51%
2009 -HK$1.73 Billion-27.37%
2008 -HK$2.38 Billion3.36%
2007 -HK$2.3 Billion27.18%
2006 -HK$1.81 Billion101.63%
2005 -HK$0.9 Billion50.46%
2004 -HK$0.6 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$82.95 B 752,636.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$195.90 B 1,777,575.91%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
HK$243.78 B 2,212,053.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$103.01 B 934,654.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$3.65 B 33,082.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-HK$1.22 Billion-11,150.96%๐Ÿ‡บ๐Ÿ‡ธ USA